Robot-assisted laparoscopic myomectomy had significantly longer operative time than laparoscopic myomectomy (adjusted geometric mean of 195.1 compared Z-IETD-FMK with 118.3 minutes, P<.001) and higher estimated blood loss (adjusted geometric mean of 110.0 compared with 85.9 mL, P=.04), but postoperative complications were similar.

CONCLUSION: Robot-assisted laparoscopic myomectomy and laparoscopic myomectomy have similar operative outcomes in a high-volume surgical practice.

Operative time and intraoperative estimated blood loss were significantly greater in the robot-assisted laparoscopic myomectomy group, but the level of statistical significance for intraoperative estimated blood loss was marginal and the clinical significance was undetermined. Use of barbed suture in the laparoscopic myomectomy group may account for these differences. (Obstet Gynecol 2012; 120:284-91) DOI:10.1097/AOG.0b013e3182602c7d”
“Objective: To monitor the changes in corneal

thickness during the corneal collagen cross-linking procedure by using isotonic riboflavin solution without dextran in ectatic corneal diseases.

Materials and Methods: The corneal thickness measurements were obtained before epithelial removal, after epithelial removal, EPZ004777 purchase following the instillation of isotonic riboflavin solution without dextran for 30 min, and after 10 min of ultraviolet A irradiation.

Results: Eleven eyes of eleven patients with progressive keratoconus (n = 10) and iatrogenic corneal ectasia (n = 1) were included in this study. The mean thinnest pachymetric measurements were 391.82 +/- 30.34 mu m (320-434 mu m) after de-epithelialization of the cornea, 435 +/- 21.17 mu m (402-472 mu m) following 30 min instillation of isotonic riboflavin solution without dextran and 431.73 +/- 20.64 mu m (387-461 mu m) following 10 min of ultraviolet A irradiation to the cornea.

Conclusion: Performing corneal cross-linking procedure with isotonic riboflavin solution without dextran might not induce corneal thinning but a little swelling throughout the procedure.”
“OBJECTIVE: To estimate the incidence, risk factors, and characteristics

of neuropathic pain related to nerve entrapment after uterosacral ligament suspension.

METHOD: A review of patients who underwent uterosacral ligament LY2090314 PI3K/Akt/mTOR inhibitor suspension from January 2007 to August 2011 was performed. Patients with neuropathic pain attributable to nerve entrapment from uterosacral ligament suspensory suture placement were identified. Factors including surgeon’s dominant hand, side of pain, onset of pain, day of suture removal, number of sutures placed and removed, patient age, and body mass index (BMI) were collected. Follow-up of patients with neuropathic pain was performed at postoperative visits and by telephone contact.

RESULT: Eight (1.6%) of 515 patients had neuropathic pain requiring suture removal from the affected side.